Xenogeneic cell therapy: current progress and future developments in porcine cell transplantation

Area of Science:

• Regenerative Medicine
• Cellular Therapy
• Xenotransplantation

Background:

• Degenerative diseases and injuries involve cell death or dysfunction, creating a need for cell transplantation.
• Current cell transplantation therapies are limited by the scarcity of suitable human cells for clinical use.
• Challenges in expanding primary human cells in culture and deriving sufficient stem cells hinder cell therapy advancements.

Purpose of the Study:

• To explore the potential of pigs as a source of primary cells for advancing cell therapy.
• To review the advantages and disadvantages of xenogeneic cell therapy for human diseases.
• To highlight the utility of porcine cells for treating human conditions.

Main Methods:

• Review of existing literature on cell therapy, xenotransplantation, and porcine cell sources.
• Analysis of the limitations of current human cell sources for transplantation.
• Evaluation of the potential of porcine primary cells in regenerative medicine.

Main Results:

• Pigs provide a viable source of diverse primary cells for transplantation.
• Xenogeneic cell therapy presents both opportunities and challenges for clinical application.
• Porcine cells show significant potential for therapeutic use in human diseases.

Conclusions:

• Primary cells from pigs are a promising alternative to address the shortage of human cells for transplantation.
• Further research into xenogeneic cell therapy using porcine cells can advance treatments for degenerative diseases.
• Utilizing porcine cells can help realize the full potential of cell transplantation as a therapeutic platform.